Boardroom Alpha
Meeting calendar
GERN · Annual meeting · Wednesday, May 20, 2026

Geron Corp

3 nominees · 4 ballot items.

Election of three Class III directors; Approval of amendment to 2018 Equity Incentive Plan increasing share reserve by 4,500,000 and ISO limit by 9,000,000; Advisory vote to approve named executive officer compensation (“say-on-pay”); Ratification of Ernst & Young LLP as independent auditors for fiscal 2026.

Market cap
$924M
1Y TSR
+6.5%
Board grade
C-
Record date
Mar 26, 2026
Filing
DEF 14A
Meeting concluded · May 20, 2026

Follow how the vote landed and what changed on Geron Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect three Class III director nominees—Patricia S. Andrews, Constantine Chinoporos, and Susan M. Molineaux, Ph.D.—to hold office until the 2029 annual meeting.

  2. 2

    Approval of an Amendment to Our 2018 Equity Incentive Plan

    ManagementBoard: FOR

    Approve amendment and restatement of the 2018 Equity Incentive Plan to increase shares available by 4,500,000 and increase ISO limit by 9,000,000, with other plan changes described in Appendix A.

    More detail

    This management proposal asks shareholders to approve an amendment and restatement of the Company’s 2018 Equity Incentive Plan to increase the share reserve by 4,500,000 shares and to increase the aggregate maximum number of shares that may be issued upon exercise of incentive stock options by 9,000,000 shares. Management and the Compensation Committee are seeking shareholder approval because the plan is the principal vehicle for granting equity-based compensation to employees, non-employee directors and consultants; the company recently became commercial-stage with RYTELO revenues and anticipates ongoing hiring and equity grant needs for commercialization and development. The filing details the company’s prior increases to the plan and current remaining shares available, and explains that the requested increase is expected to meet approximately one year of equity needs based on hiring, director grants, and forfeiture assumptions. The amendment incorporates governance protections: no repricing without stockholder approval, fungible share counting (1.0 for options, 1.3 for full-value awards post-May 31, 2023), limits on non-employee director compensation, and standard change-in-control and anti-dilution adjustment provisions. The Compensation Committee, with support of an independent compensation consultant, argues the increase is reasonable in view of peer practices and the need to balance dilution with recruitment and retention. The board recommends a FOR vote, citing alignment of equity awards with pay-for-performance, retention of talent during commercialization, and avoidance of excessive cash compensation. Risks include dilution, and the company discloses its burn rate and historical grant practices. The proposal includes the full Amended 2018 Plan as Appendix A and discusses share recycling rules, the Inducement Plan, and other governance features.

  3. 3

    Advisory Vote to Approve Named Executive Officer Compensation

    ManagementBoard: FOR

    Non-binding, advisory 'say-on-pay' to approve the compensation of the Company's named executive officers as disclosed in the proxy.

    More detail

    This advisory management proposal requests shareholder approval, on a non-binding basis, of the compensation paid to the company’s named executive officers as disclosed in the proxy statement. Management frames the program as pay-for-performance, with a mix of base salary, performance-based annual cash bonuses tied to corporate and individual goals, and long-term equity incentives (primarily stock options and RSUs) to align executives’ interests with shareholders. The Compensation Committee used market peer data and an independent consultant to set targets and concluded that a significant portion of CEO pay is at-risk. The board recommends a FOR vote. As an advisory vote, the outcome is non-binding but will inform the board and Compensation Committee’s decisions going forward.

  4. 4

    Ratification of Selection of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of Ernst & Young LLP as the company’s independent registered public accounting firm for fiscal year ending December 31, 2026.

Director elections

Nominees on the ballot3

Independent
Tenure on this board
0.3 yrs
Also a director at
Oncolytics Biotech Inc (ONCY)
Ownership

Top institutional holders10

Latest 13F quarter
1RA CAPITAL MANAGEMENT, L.P.9.9%63,771,366$95M
2Soleus Capital Management, L.P.6.5%41,508,659$62M
3Deep Track Capital, LP4.9%31,720,278$47M
4STATE STREET CORP4.8%30,497,183$45M
5VANGUARD CAPITAL MANAGEMENT LLC4.2%26,669,029$40M
6BlackRock, Inc.3.8%24,194,523$36M
7Point72 Asset Management, L.P.Activist3.2%20,457,134$30M
8Clearbridge Investments, LLC3.1%19,620,320$29M
9Eversept Partners, LP2.9%18,834,883$28M
10CITADEL ADVISORS LLC2.7%17,473,196$26M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Geron Corp 2026 annual meeting?
Geron Corp (GERN) holds its 2026 annual shareholder meeting on Wednesday, May 20, 2026.
What is the record date for the Geron Corp 2026 meeting?
The record date for the Geron Corp 2026 meeting is Thursday, March 26, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Geron Corp's 2026 meeting?
The board is presenting 3 director nominees at the Geron Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Geron Corp 2026 meeting?
Shareholders will vote on 4 proposals at the Geron Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer